Oruka Therapeutics, Inc. (ORKA)
60.65
+3.15
(+5.48%)
USD |
NASDAQ |
May 20, 16:00
61.55
+0.90
(+1.48%)
After-Hours: 20:00
Oruka Therapeutics Free Cash Flow : -91.19M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liminatus Pharma, Inc. | -11.99M |
| MapLight Therapeutics, Inc. | -164.26M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 155.34M |
| Insight Molecular Diagnostics, Inc. | -27.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.58M |
| Cash from Investing (Quarterly) | -14.44M |
| Cash from Financing (Quarterly) | 40.60M |
| Free Cash Flow Per Share (Quarterly) | -0.4287 |
| Free Cash Flow to Equity (Quarterly) | -23.53M |
| Free Cash Flow to Firm (Quarterly) | -23.65M |
| Free Cash Flow Yield | -3.07% |